drug shortage shows vulnerability of the
As became scarce, oncologists switched to , another common therapy, which Intas also produced. With Intas no longer producing carboplatin & increasing demand, that medicine is now also in short supply. It was β€œlike a ripple effect in the supply chain,” Socal says.
Survey of US cancer centers in May revealed that a whopping 93% were experiencing shortages of carboplatin.
technologyreview.com/2023/08/1

#chemo #healthcare #supplychain #cisplatin #carboplatin #cancer

Last updated 1 year ago

Erika Hamilton, MD · @ErikaHamilton9
62 followers · 189 posts · Server med-mastodon.com

RT @matteolambe@twitter.com

Finally the controversy on use as part of neoadjuvant in triple-negative patients is over: super congrats to our Indian colleagues for running such an important academic trial!

@OncoAlert@twitter.com @SABCSSanAntonio@twitter.com @Poggio_Fra@twitter.com

πŸ¦πŸ”—: twitter.com/matteolambe/status

#carboplatin #chemotherapy #breastcancer #bcsm #SABCS22

Last updated 2 years ago